{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:44:16Z","timestamp":1790855056686,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-03925-7","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T16:32:45Z","timestamp":1772296365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Common and rare variant contributions to discontinuation of stimulant treatment in ADHD"],"prefix":"10.1038","volume":"16","author":[{"given":"Janne Pia","family":"Thirstrup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3402-302X","authenticated-orcid":false,"given":"Jinjie","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1039-1116","authenticated-orcid":false,"given":"Marta","family":"Ribases Haro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3213-1107","authenticated-orcid":false,"given":"Maria","family":"Soler Artigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Albi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4659-0969","authenticated-orcid":false,"given":"S\u00f8ren","family":"Dalsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9217-3982","authenticated-orcid":false,"given":"Stephen V.","family":"Faraone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1829-0766","authenticated-orcid":false,"given":"Thomas","family":"Werge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1705-4008","authenticated-orcid":false,"given":"Jonas","family":"Bybjerg-Grauholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8627-7219","authenticated-orcid":false,"given":"Anders D.","family":"B\u00f8rglum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben","family":"Agerbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghui","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Brikell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9124-2766","authenticated-orcid":false,"given":"Ditte","family":"Demontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"3925_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-024-00495-0","volume":"10","author":"SV Faraone","year":"2024","unstructured":"Faraone SV, Bellgrove MA, Brikell I, Cortese S, Hartman CA, Hollis C, et al. Attention-deficit\/hyperactivity disorder. Nat Rev Dis Primers. 2024;10:11. https:\/\/doi.org\/10.1038\/s41572-024-00495-0.","journal-title":"Nat Rev Dis Primers"},{"key":"3925_CR2","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1056\/NEJMra1917069","volume":"383","author":"S Cortese","year":"2020","unstructured":"Cortese S. Pharmacologic treatment of attention deficit\u2013hyperactivity disorder. N Engl J Med. 2020;383:1050\u20136. https:\/\/doi.org\/10.1056\/NEJMra1917069.","journal-title":"N Engl J Med"},{"key":"3925_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.biopsych.2019.04.009","volume":"86","author":"Z Chang","year":"2019","unstructured":"Chang Z, Ghirardi L, Quinn PD, Asherson P, D\u2019Onofrio BM, Larsson H. Risks and benefits of attention-deficit\/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases. Biol Psychiatry. 2019;86:335\u201343. https:\/\/doi.org\/10.1016\/j.biopsych.2019.04.009.","journal-title":"Biol Psychiatry"},{"key":"3925_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S2215-0366(25)00062-8","volume":"12","author":"LC Farhat","year":"2025","unstructured":"Farhat LC, Lannes A, Del Giovane C, Parlatini V, Garcia-Argibay M, Ostinelli EG, et al. Comparative cardiovascular safety of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2025;12:355\u201365. https:\/\/doi.org\/10.1016\/S2215-0366(25)00062-8.","journal-title":"Lancet Psychiatry"},{"key":"3925_CR5","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.2147\/NDT.S65721","volume":"10","author":"K Gajria","year":"2014","unstructured":"Gajria K, Lu M, Sikirica V, Greven P, Zhong Y, Qin P, et al. Adherence, persistence, and medication discontinuation in patients with attention-deficit\/hyperactivity disorder - a systematic literature review. Neuropsychiatric Dis Treat. 2014;10:1543\u201369. https:\/\/doi.org\/10.2147\/NDT.S65721.","journal-title":"Neuropsychiatric Dis Treat"},{"key":"3925_CR6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1089\/cap.2018.0153","volume":"29","author":"MU Khan","year":"2019","unstructured":"Khan MU, Aslani P. A review of factors influencing the three phases of medication adherence in people with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2019;29:398\u2013418. https:\/\/doi.org\/10.1089\/cap.2018.0153.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"3925_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/s2215-0366(23)00332-2","volume":"11","author":"I Brikell","year":"2024","unstructured":"Brikell I, Yao H, Li L, Astrup A, Gao L, Gillies MB, et al. ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases. Lancet Psychiatry. 2024;11:16\u201326. https:\/\/doi.org\/10.1016\/s2215-0366(23)00332-2.","journal-title":"Lancet Psychiatry"},{"key":"3925_CR8","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1176\/appi.ps.201800515","volume":"70","author":"J Biederman","year":"2019","unstructured":"Biederman J, Fried R, DiSalvo M, Storch B, Pulli A, Woodworth KY, et al. Evidence of low adherence to stimulant medication among children and youths with adhd: an electronic health records study. Psychiatr Services, appips. 2019;70:874\u201380. https:\/\/doi.org\/10.1176\/appi.ps.201800515.","journal-title":"Psychiatr Services, appips"},{"key":"3925_CR9","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1007\/s00213-020-05576-y","volume":"237","author":"J Biederman","year":"2020","unstructured":"Biederman J, Fried R, DiSalvo M, Woodworth KY, Biederman I, Driscoll H, et al. Further evidence of low adherence to stimulant treatment in adult ADHD: an electronic medical record study examining timely renewal of a stimulant prescription. Psychopharmacology. 2020;237:2835\u201343. https:\/\/doi.org\/10.1007\/s00213-020-05576-y.","journal-title":"Psychopharmacology"},{"key":"3925_CR10","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.biopsych.2024.01.001","volume":"96","author":"E Koch","year":"2024","unstructured":"Koch E, Pardi\u00f1as AF, O\u2019Connell KS, Selvaggi P, Camacho Collados J, Babic A, et al. How real-world data can facilitate the development of precision medicine treatment in psychiatry. Biol Psychiatry. 2024;96:543\u201351. https:\/\/doi.org\/10.1016\/j.biopsych.2024.01.001.","journal-title":"Biol Psychiatry"},{"key":"3925_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/mp.2017.234","volume":"23","author":"NM Myer","year":"2018","unstructured":"Myer NM, Boland JR, Faraone SV. Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD. Mol Psychiatry. 2018;23:1\u20138. https:\/\/doi.org\/10.1038\/mp.2017.234.","journal-title":"Mol Psychiatry"},{"key":"3925_CR12","doi-asserted-by":"publisher","first-page":"e27858","DOI":"10.1097\/md.0000000000027858","volume":"100","author":"D Yuan","year":"2021","unstructured":"Yuan D, Zhang M, Huang Y, Wang X, Jiao J, Huang Y. Noradrenergic genes polymorphisms and response to methylphenidate in children with ADHD: a systematic review and meta-analysis. Medicine. 2021;100:e27858. https:\/\/doi.org\/10.1097\/md.0000000000027858.","journal-title":"Medicine"},{"key":"3925_CR13","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/ajmg.b.30865","volume":"147","author":"E Mick","year":"2008","unstructured":"Mick E, Neale B, Middleton FA, McGough JJ, Faraone SV. Genome-wide association study of response to methylphenidate in 187 children with attention-deficit\/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2008;147:1412\u20138. https:\/\/doi.org\/10.1002\/ajmg.b.30865.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"3925_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20194-7","volume":"8","author":"M Pagerols","year":"2018","unstructured":"Pagerols M, Richarte V, S\u00e1nchez-Mora C, Rovira P, Soler Artigas M, Garcia-Mart\u00ednez I, et al. Integrative genomic analysis of methylphenidate response in attention-deficit\/hyperactivity disorder. Sci Rep. 2018;8:1881. https:\/\/doi.org\/10.1038\/s41598-018-20194-7.","journal-title":"Sci Rep"},{"key":"3925_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.pnpbp.2010.11.037","volume":"35","author":"E Mick","year":"2011","unstructured":"Mick E, McGough JJ, Middleton FA, Neale B, Faraone SV. Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit\/hyperactivity disorder. Prog Neuro-psychopharmacol Biol Psychiatry. 2011;35:466\u201372. https:\/\/doi.org\/10.1016\/j.pnpbp.2010.11.037.","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"3925_CR16","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1176\/appi.ajp.2020.20121686","volume":"178","author":"I Brikell","year":"2021","unstructured":"Brikell I, Wimberley T, Albinana C, Pedersen EM, Vilhjalmsson BJ, Agerbo E, et al. Genetic, clinical, and sociodemographic factors associated with stimulant treatment outcomes in ADHD. Am J psychiatry. 2021;178:854\u201364. https:\/\/doi.org\/10.1176\/appi.ajp.2020.20121686.","journal-title":"Am J psychiatry"},{"key":"3925_CR17","doi-asserted-by":"crossref","unstructured":"Bybjerg-Grauholm J, Pedersen CB, B\u00e6kvad-Hansen M, Pedersen MG, Adamsen D, Hansen CS et al. The iPSYCH2015 Case-Cohort sample: updated directions for unravelling genetic and environmental architectures of severe mental disorders. medRxiv 2020.2011.2030.20237768 [Preprint]. 2020. Available from: https:\/\/www.medrxiv.org\/content\/10.1101\/2020.11.30.20237768v1.","DOI":"10.1101\/2020.11.30.20237768"},{"key":"3925_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/mp.2017.196","volume":"23","author":"CB Pedersen","year":"2018","unstructured":"Pedersen CB, Bybjerg-Grauholm J, Pedersen MG, Grove J, Agerbo E, B\u00e6kvad-Hansen M, et al. The iPSYCH2012 case\u2013cohort sample: new directions for unravelling genetic and environmental architectures of severe mental disorders. Mol Psychiatry. 2018;23:6\u201314. https:\/\/doi.org\/10.1038\/mp.2017.196.","journal-title":"Mol Psychiatry"},{"key":"3925_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41588-022-01285-8","volume":"55","author":"D Demontis","year":"2023","unstructured":"Demontis D, Walters GB, Athanasiadis G, Walters R, Therrien K, Nielsen TT, et al. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nat Genet. 2023;55:198\u2013208. https:\/\/doi.org\/10.1038\/s41588-022-01285-8.","journal-title":"Nat Genet"},{"key":"3925_CR20","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1038\/s41593-019-0527-8","volume":"22","author":"FK Satterstrom","year":"2019","unstructured":"Satterstrom FK, Walters RK, Singh T, Wigdor EM, Lescai F, Demontis D, et al. Autism spectrum disorder and attention deficit hyperactivity disorder have a similar burden of rare protein-truncating variants. Nat Neurosci. 2019;22:1961\u20135. https:\/\/doi.org\/10.1038\/s41593-019-0527-8.","journal-title":"Nat Neurosci"},{"key":"3925_CR21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41588-022-01143-7","volume":"54","author":"VM Rajagopal","year":"2022","unstructured":"Rajagopal VM, Duan J, Vilar-Rib\u00f3 L, Grove J, Zayats T, Ramos-Quiroga JA, et al. Differences in the genetic architecture of common and rare variants in childhood, persistent and late-diagnosed attention-deficit hyperactivity disorder. Nat Genet. 2022;54:1117\u201324. https:\/\/doi.org\/10.1038\/s41588-022-01143-7.","journal-title":"Nat Genet"},{"key":"3925_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi6856","volume":"7","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Arribas GH, Turku A, J\u00fcrgenson T, Mkrtchian S, Krebs K, et al. Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine. Sci Adv. 2021;7:eabi6856. https:\/\/doi.org\/10.1126\/sciadv.abi6856.","journal-title":"Sci Adv"},{"key":"3925_CR23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/1403494810395825","volume":"39","author":"O Mors","year":"2011","unstructured":"Mors O, Perto GP, Mortensen PB. The danish psychiatric central research register. Scand J public health. 2011;39:54\u201357. https:\/\/doi.org\/10.1177\/1403494810395825.","journal-title":"Scand J public health"},{"key":"3925_CR24","first-page":"798","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H, S\u00f8rensen HT, Hallas J, Schmidt M. Data resource profile: the danish national prescription registry. Int J Epidemiol. 2017;46:798\u2013798f.","journal-title":"Int J Epidemiol"},{"key":"3925_CR25","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1093\/bioinformatics\/bty185","volume":"34","author":"F Priv\u00e9","year":"2018","unstructured":"Priv\u00e9 F, Aschard H, Ziyatdinov A, Blum MGB. Efficient analysis of large-scale genome-wide data with two R packages: bigstatsr and bigsnpr. Bioinformatics. 2018;34:2781\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/bty185.","journal-title":"Bioinformatics"},{"key":"3925_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13742-015-0047-8","volume":"4","author":"CC Chang","year":"2015","unstructured":"Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015;4:7. https:\/\/doi.org\/10.1186\/s13742-015-0047-8.","journal-title":"Gigascience"},{"key":"3925_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ajhg.2010.11.011","volume":"88","author":"J Yang","year":"2011","unstructured":"Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88:76\u201382. https:\/\/doi.org\/10.1016\/j.ajhg.2010.11.011.","journal-title":"Am J Hum Genet"},{"key":"3925_CR28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.ajhg.2021.04.014","volume":"108","author":"C Albi\u00f1ana","year":"2021","unstructured":"Albi\u00f1ana C, Grove J, McGrath JJ, Agerbo E, Wray NR, Bulik CM, et al. Leveraging both individual-level genetic data and GWAS summary statistics increases polygenic prediction. Am J Hum Genet. 2021;108:1001\u201311. https:\/\/doi.org\/10.1016\/j.ajhg.2021.04.014.","journal-title":"Am J Hum Genet"},{"key":"3925_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40330-w","volume":"14","author":"C Albi\u00f1ana","year":"2023","unstructured":"Albi\u00f1ana C, Zhu Z, Schork AJ, Ingason A, Aschard H, Brikell I, et al. Multi-PGS enhances polygenic prediction by combining 937 polygenic scores. Nat Commun. 2023;14:4702. https:\/\/doi.org\/10.1038\/s41467-023-40330-w.","journal-title":"Nat Commun"},{"key":"3925_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1375\/twin.14.6.495","volume":"14","author":"H Anckarsater","year":"2011","unstructured":"Anckarsater H, Lundstrom S, Kollberg L, Kerekes N, Palm C, Carlstrom E, et al. The Child and Adolescent Twin Study in Sweden (CATSS). Twin Res Hum Genet. 2011;14:495\u2013508.","journal-title":"Twin Res Hum Genet"},{"key":"3925_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-01035-6","volume":"10","author":"QS Li","year":"2020","unstructured":"Li QS, Tian C, Hinds D, Agee M, Alipanahi B, Auton A, et al. Genome-wide association studies of antidepressant class response and treatment-resistant depression. Transl Psychiatry. 2020;10:360. https:\/\/doi.org\/10.1038\/s41398-020-01035-6.","journal-title":"Transl Psychiatry"},{"key":"3925_CR32","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1177\/10870547231177234","volume":"27","author":"M Pagnier","year":"2023","unstructured":"Pagnier M. Predicting the response of children and adolescents with ADHD to methylphenidate: a systematic review. J Atten Disord. 2023;27:1377\u201392. https:\/\/doi.org\/10.1177\/10870547231177234.","journal-title":"J Atten Disord"},{"key":"3925_CR33","unstructured":"Robbins, L & Maides, J Efficacy of stimulants in migraineurs with comorbidities. Practical Pain Manag 2009;9."},{"key":"3925_CR34","doi-asserted-by":"publisher","first-page":"e2243597","DOI":"10.1001\/jamanetworkopen.2022.43597","volume":"5","author":"L Zhang","year":"2022","unstructured":"Zhang L, Yao H, Li L, Du Rietz E, Andell P, Garcia-Argibay M, et al. Risk of cardiovascular diseases associated with medications used in attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis. JAMA Netw Open. 2022;5:e2243597\u2013e2243597. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.43597.","journal-title":"JAMA Netw Open"},{"key":"3925_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jpsychires.2022.07.032","volume":"155","author":"A Green","year":"2022","unstructured":"Green A, Baroud E, DiSalvo M, Faraone SV, Biederman J. Examining the impact of ADHD polygenic risk scores on ADHD and associated outcomes: a systematic review and meta-analysis. J Psychiatr Res. 2022;155:49\u201367. https:\/\/doi.org\/10.1016\/j.jpsychires.2022.07.032.","journal-title":"J Psychiatr Res"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03925-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03925-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03925-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:39:22Z","timestamp":1773401962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-03925-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3925"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-03925-7","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ditte Demontis has received speaker fee from Medice Nordic and Takeda. Anders D. B\u00f8rglum has received speaker fee from Lundbeck. Zheng Chang has received speaker fees from Takeda Pharmaceuticals. In the past year, Stephen Faraone received income, potential income, travel expenses continuing education support and\/or research support from Aardvark, Aardwolf, Otsuka, Collegium, Corium, Supernus, and Mentavi. With his institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. He receives royalties from books published by Guilford Press: Straight Talk about Your Child\u2019s Mental Health, Oxford University Press: Schizophrenia: The Facts and Elsevier: ADHD: Non-Pharmacologic Interventions. All other authors report no biomedical financial interests or potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"iPSYCH was approved by the Danish Scientific Ethics Committee, the Danish Health Data Authority, the Danish Data Protection Agency, and Danish Newborn Screening Biobank Steering Committee. In accordance with Danish legislation, the Danish Scientific Ethics Committee has waived the need for informed consent in biomedical research based on existing biobanks. All data were de-identified and not recognizable at an individual level. This study did not involve lived experience. iPSYCH was approved by the Ethics Committee initially in 2012, with subsequent amendments in 2013, 2015, and 2018. More details can be found at URL:\n                      \n                      . New Danish legislation (effective from January 2024) introduces the possibility for participants to opt out of studies that are exempt from active informed consent. After consulting with the Ethics Committees and patient organizations, iPSYCH contacted all participants in the iPSYCH cohort in June 2025 and offered the possibility to opt out of new genetic studies initiated henceforth. Overall, 1.8% of the iPSYCH participants chose to opt out, and their data will be deleted from the active research database. Data included in finalized and ongoing studies will not be removed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"144"}}